Worldwide revenue from the sales of Treponema pallidum test kits is expected to reach US$ 204.6 million in 2024. The global Treponema pallidum test market is analyzed to climb to a value of US$ 360 million by the end of 2034, expanding at a CAGR of 5.8%.This growth reflects increasing syphilis prevalence, technological advancements in diagnostics, and heightened public health focus on...